1. Home
  2. Analysis
  3. Spironolactone
  4. Ovcon-35

Spironolactone and Ovcon-35 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 10 people who take Spironolactone and Ovcon-35. Common interactions include abdominal pain upper among females.

The phase IV clinical study analyzes what interactions people who take Spironolactone and Ovcon-35 have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

On Sep, 25, 2023

10 people who take Spironolactone and Ovcon-35 together, and have interactions are studied.

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is used in acne. Currently, eHealthMe is studying from 113,577 Spironolactone users.

What is Ovcon-35?

Ovcon-35 has active ingredients of ethinyl estradiol; norethindrone. It is used in birth control. Currently, eHealthMe is studying from 378 Ovcon-35 users.

Number of Spironolactone and Ovcon-35 reports submitted per year:

Spironolactone and Ovcon-35 drug interactions.

Common Spironolactone and Ovcon-35 drug interactions by gender *:

female:

  1. Abdominal pain upper
  2. Cholecystitis chronic
  3. Abdominal pain
  4. Gastrooesophageal reflux disease
  5. Menstruation irregular
  6. Pelvic pain
  7. Weight increased
  8. Cholecystitis acute
  9. Cholelithiasis
  10. Injury

male:

n/a

Common Spironolactone and Ovcon-35 drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain upper
  2. Abdominal tenderness
  3. Biliary dyskinesia
  4. Cholecystitis chronic
  5. Epigastric discomfort
  6. Gastrooesophageal reflux disease
  7. Menstruation irregular
  8. Nausea
  9. Pain
  10. Pelvic pain

30-39:

  1. Abdominal pain upper
  2. Cholecystitis acute
  3. Cholecystitis chronic
  4. Cholelithiasis
  5. Injury
  6. Bladder pain
  7. Drug ineffective
  8. Dry mouth

40-49:

n/a

50-59:

n/a

60+:

n/a

Common conditions people have *:

  1. Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 8 people, 80.00%
  2. Premenstrual Syndrome: 6 people, 60.00%
  3. Herpes Simplex (herpes simplex is a common viral infection): 6 people, 60.00%
  4. Asthma: 6 people, 60.00%
  5. Acne Cystic (skin problems that cause pimples): 6 people, 60.00%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 40.00%
  7. Thyroid Cancer: 1 person, 10.00%
  8. Cushing's Syndrome (obesity, a rounded face, increased fat): 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Spironolactone and Ovcon-35?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Spironolactone side effects:

Browse all side effects of Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Spironolactone interactions:

Browse all interactions between Spironolactone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on spironolactone and ethinyl estradiol; norethindrone (the active ingredients of Spironolactone and Ovcon-35, respectively), and Spironolactone and Ovcon-35 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Spironolactone and Ovcon-35.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.